Leigh Syndrome: A Tale of Two Genomes

Leigh syndrome is a rare, complex, and incurable early onset (typically infant or early childhood) mitochondrial disorder with both phenotypic and genetic heterogeneity. The heterogeneous nature of this disorder, based in part on the complexity of mitochondrial genetics, and the significant interact...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in physiology 2021-08, Vol.12, p.693734-693734
Main Authors: Bakare, Ajibola B, Lesnefsky, Edward J, Iyer, Shilpa
Format: Article
Language:English
Subjects:
Leigh syndrome
mitochondria
mitochondrial DNA
mitochondrial genetics
Physiology
respiratory chain complex
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c531t-10abb496633673867f76e79788b53a91db42e57eae7c22c3a4f32d8d5a8c322a3
cites cdi_FETCH-LOGICAL-c531t-10abb496633673867f76e79788b53a91db42e57eae7c22c3a4f32d8d5a8c322a3
container_end_page 693734
container_issue
container_start_page 693734
container_title Frontiers in physiology
container_volume 12
creator Bakare, Ajibola B
Lesnefsky, Edward J
Iyer, Shilpa
description Leigh syndrome is a rare, complex, and incurable early onset (typically infant or early childhood) mitochondrial disorder with both phenotypic and genetic heterogeneity. The heterogeneous nature of this disorder, based in part on the complexity of mitochondrial genetics, and the significant interactions between the nuclear and mitochondrial genomes has made it particularly challenging to research and develop therapies. This review article discusses some of the advances that have been made in the field to date. While the prognosis is poor with no current substantial treatment options, multiple studies are underway to understand the etiology, pathogenesis, and pathophysiology of Leigh syndrome. With advances in available research tools leading to a better understanding of the mitochondria in health and disease, there is hope for novel treatment options in the future.
doi_str_mv 10.3389/fphys.2021.693734
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_17f6fa0783864f2da69a8b8b4eb89f8e</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_17f6fa0783864f2da69a8b8b4eb89f8e</doaj_id><sourcerecordid>2566262761</sourcerecordid><originalsourceid>FETCH-LOGICAL-c531t-10abb496633673867f76e79788b53a91db42e57eae7c22c3a4f32d8d5a8c322a3</originalsourceid><addsrcrecordid>eNpVkUtLAzEQgIMotqg_wIvsRfDSmtcmWQ9CKb6g4MEK3sLs7qTdst3UpFX6741WRXOZMI9vQj5CThkdCmGKS7eab-OQU86GqhBayD3SZ0rJAZX8Zf_PvUdOYlzQdCTllLJD0hNS5kpL1SfnE2xm8-xp29XBL_EqG2VTaDHzLpu---wOu5SNx-TAQRvx5Dsekefbm-n4fjB5vHsYjyaDKhdsPWAUylIWSgmhtDBKO61QF9qYMhdQsLqUHHONgLrivBIgneC1qXMwleAcxBF52HFrDwu7Cs0SwtZ6aOxXwoeZhbBuqhYt0045oNqkPdLxGlQBpjSlxNIUzmBiXe9Yq025xLrCbh2g_Qf9X-mauZ35N5uIefqfBLj4BgT_usG4tssmVti20KHfRMtzpbjiWrHUynatVfAxBnS_axi1n7bsly37acvubKWZs7_v-534cSM-AK8nj5c</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2566262761</pqid></control><display><type>article</type><title>Leigh Syndrome: A Tale of Two Genomes</title><source>Open Access: PubMed Central</source><creator>Bakare, Ajibola B ; Lesnefsky, Edward J ; Iyer, Shilpa</creator><creatorcontrib>Bakare, Ajibola B ; Lesnefsky, Edward J ; Iyer, Shilpa</creatorcontrib><description>Leigh syndrome is a rare, complex, and incurable early onset (typically infant or early childhood) mitochondrial disorder with both phenotypic and genetic heterogeneity. The heterogeneous nature of this disorder, based in part on the complexity of mitochondrial genetics, and the significant interactions between the nuclear and mitochondrial genomes has made it particularly challenging to research and develop therapies. This review article discusses some of the advances that have been made in the field to date. While the prognosis is poor with no current substantial treatment options, multiple studies are underway to understand the etiology, pathogenesis, and pathophysiology of Leigh syndrome. With advances in available research tools leading to a better understanding of the mitochondria in health and disease, there is hope for novel treatment options in the future.</description><identifier>ISSN: 1664-042X</identifier><identifier>EISSN: 1664-042X</identifier><identifier>DOI: 10.3389/fphys.2021.693734</identifier><identifier>PMID: 34456746</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>Leigh syndrome ; mitochondria ; mitochondrial DNA ; mitochondrial genetics ; Physiology ; respiratory chain complex</subject><ispartof>Frontiers in physiology, 2021-08, Vol.12, p.693734-693734</ispartof><rights>Copyright © 2021 Bakare, Lesnefsky and Iyer.</rights><rights>Copyright © 2021 Bakare, Lesnefsky and Iyer. 2021 Bakare, Lesnefsky and Iyer</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c531t-10abb496633673867f76e79788b53a91db42e57eae7c22c3a4f32d8d5a8c322a3</citedby><cites>FETCH-LOGICAL-c531t-10abb496633673867f76e79788b53a91db42e57eae7c22c3a4f32d8d5a8c322a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385445/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385445/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34456746$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bakare, Ajibola B</creatorcontrib><creatorcontrib>Lesnefsky, Edward J</creatorcontrib><creatorcontrib>Iyer, Shilpa</creatorcontrib><title>Leigh Syndrome: A Tale of Two Genomes</title><title>Frontiers in physiology</title><addtitle>Front Physiol</addtitle><description>Leigh syndrome is a rare, complex, and incurable early onset (typically infant or early childhood) mitochondrial disorder with both phenotypic and genetic heterogeneity. The heterogeneous nature of this disorder, based in part on the complexity of mitochondrial genetics, and the significant interactions between the nuclear and mitochondrial genomes has made it particularly challenging to research and develop therapies. This review article discusses some of the advances that have been made in the field to date. While the prognosis is poor with no current substantial treatment options, multiple studies are underway to understand the etiology, pathogenesis, and pathophysiology of Leigh syndrome. With advances in available research tools leading to a better understanding of the mitochondria in health and disease, there is hope for novel treatment options in the future.</description><subject>Leigh syndrome</subject><subject>mitochondria</subject><subject>mitochondrial DNA</subject><subject>mitochondrial genetics</subject><subject>Physiology</subject><subject>respiratory chain complex</subject><issn>1664-042X</issn><issn>1664-042X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkUtLAzEQgIMotqg_wIvsRfDSmtcmWQ9CKb6g4MEK3sLs7qTdst3UpFX6741WRXOZMI9vQj5CThkdCmGKS7eab-OQU86GqhBayD3SZ0rJAZX8Zf_PvUdOYlzQdCTllLJD0hNS5kpL1SfnE2xm8-xp29XBL_EqG2VTaDHzLpu---wOu5SNx-TAQRvx5Dsekefbm-n4fjB5vHsYjyaDKhdsPWAUylIWSgmhtDBKO61QF9qYMhdQsLqUHHONgLrivBIgneC1qXMwleAcxBF52HFrDwu7Cs0SwtZ6aOxXwoeZhbBuqhYt0045oNqkPdLxGlQBpjSlxNIUzmBiXe9Yq025xLrCbh2g_Qf9X-mauZ35N5uIefqfBLj4BgT_usG4tssmVti20KHfRMtzpbjiWrHUynatVfAxBnS_axi1n7bsly37acvubKWZs7_v-534cSM-AK8nj5c</recordid><startdate>20210811</startdate><enddate>20210811</enddate><creator>Bakare, Ajibola B</creator><creator>Lesnefsky, Edward J</creator><creator>Iyer, Shilpa</creator><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20210811</creationdate><title>Leigh Syndrome: A Tale of Two Genomes</title><author>Bakare, Ajibola B ; Lesnefsky, Edward J ; Iyer, Shilpa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c531t-10abb496633673867f76e79788b53a91db42e57eae7c22c3a4f32d8d5a8c322a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Leigh syndrome</topic><topic>mitochondria</topic><topic>mitochondrial DNA</topic><topic>mitochondrial genetics</topic><topic>Physiology</topic><topic>respiratory chain complex</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bakare, Ajibola B</creatorcontrib><creatorcontrib>Lesnefsky, Edward J</creatorcontrib><creatorcontrib>Iyer, Shilpa</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Frontiers in physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bakare, Ajibola B</au><au>Lesnefsky, Edward J</au><au>Iyer, Shilpa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Leigh Syndrome: A Tale of Two Genomes</atitle><jtitle>Frontiers in physiology</jtitle><addtitle>Front Physiol</addtitle><date>2021-08-11</date><risdate>2021</risdate><volume>12</volume><spage>693734</spage><epage>693734</epage><pages>693734-693734</pages><issn>1664-042X</issn><eissn>1664-042X</eissn><abstract>Leigh syndrome is a rare, complex, and incurable early onset (typically infant or early childhood) mitochondrial disorder with both phenotypic and genetic heterogeneity. The heterogeneous nature of this disorder, based in part on the complexity of mitochondrial genetics, and the significant interactions between the nuclear and mitochondrial genomes has made it particularly challenging to research and develop therapies. This review article discusses some of the advances that have been made in the field to date. While the prognosis is poor with no current substantial treatment options, multiple studies are underway to understand the etiology, pathogenesis, and pathophysiology of Leigh syndrome. With advances in available research tools leading to a better understanding of the mitochondria in health and disease, there is hope for novel treatment options in the future.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>34456746</pmid><doi>10.3389/fphys.2021.693734</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1664-042X
ispartof Frontiers in physiology, 2021-08, Vol.12, p.693734-693734
issn 1664-042X
1664-042X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_17f6fa0783864f2da69a8b8b4eb89f8e
source Open Access: PubMed Central
subjects Leigh syndrome
mitochondria
mitochondrial DNA
mitochondrial genetics
Physiology
respiratory chain complex
title Leigh Syndrome: A Tale of Two Genomes
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T02%3A46%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Leigh%20Syndrome:%20A%20Tale%20of%20Two%20Genomes&rft.jtitle=Frontiers%20in%20physiology&rft.au=Bakare,%20Ajibola%20B&rft.date=2021-08-11&rft.volume=12&rft.spage=693734&rft.epage=693734&rft.pages=693734-693734&rft.issn=1664-042X&rft.eissn=1664-042X&rft_id=info:doi/10.3389/fphys.2021.693734&rft_dat=%3Cproquest_doaj_%3E2566262761%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c531t-10abb496633673867f76e79788b53a91db42e57eae7c22c3a4f32d8d5a8c322a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2566262761&rft_id=info:pmid/34456746&rfr_iscdi=true